Abuse of Gabapentin is Associated with Opioid Addiction

Psychiatric Quarterly

Volumn 87, Issue 4, 2016, Pages 763-767

  Bastiaens, Leo ^a   Galus, James ^a   Mazur, Cherise ^a  

^a Renewal Inc   (United States)

Author keywords

Correctional population; Gabapentin abuse; Opioid addiction

Indexed keywords

AMFEBUTAMONE; FLUOXETINE; GABAPENTIN; OPIATE; QUETIAPINE; 4 AMINOBUTYRIC ACID; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ADULT; ANTISOCIAL PERSONALITY DISORDER; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ABUSE; DRUG MISUSE; FEMALE; HEPATITIS C; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; POSTTRAUMATIC STRESS DISORDER; QUESTIONNAIRE; SCHIZOPHRENIA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; DEPRESSIVE DISORDER; MENTAL DISORDERS; MIDDLE AGED; OFFENDER; OPIOID-RELATED DISORDERS; PSYCHIATRIC DIAGNOSIS; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

ADULT; AMINES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; CRIMINALS; CYCLOHEXANECARBOXYLIC ACIDS; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84958753727     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-016-9421-7     Document Type: Article

References (19)

1. Volkow ND: https://www.drugabuse.gov/publications/research-reports/prescription-drugs/director, 2014.
2. Centers for Disease Control and Prevention: Vital Signs: Overdoses of prescription opioid pain relievers—United States, 1999–2008. www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm, 2011.
3. McCabe SE, Boyd CJ, Teter CJ: Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend 102:63–70, 2009.
4. McCabe SE, Teter CJ, Boyd CJ: Medical use, illicit use, and diversion of abusable prescription drugs. Journal of American College Health 54:269–278, 2006.
5. Reeves RR, Burke RS: Abuse of combinations of gabapentin and quetiapine. The Primary Care Companion for CNS Disorders 16(5):11, 2014.
6. Smith BH, Higgins C, Baldacchino A, et al.: Substance misuse of gabapentin. British Journal of General Practice 62:406–407, 2012.
7. Reccoppa L, Malcolm R, Ware M: Gabapentin abuse in inmates with prior history of cocaine dependence. American Journal on Addictions 13:321–323, 2004.
8. Del Paggio D: Psychotropic medication abuse in correctional facilities. http://www.acbhcs.org/Psychopharmacology/2005/June2005.pdf, 2005.
9. Reeves RR, Ladner ME: Additional evidence of the abuse potential of bupropion. Journal of clinical psychopharmacology 33:584–585, 2013.
10. Hilliard WT, Barloon L, Farley P, et al.: Bupropion diversion and misuse in the correctional facility. Journal of Correctional Health Care 19:211–217, 2013.
11. Wilens T, Zulauf C, Ryland D, et al.: Prescription medication misuse among opioid dependent patients seeking inpatient detoxification. The American Journal on Addictions. doi:10.1111/j.1521-0391.2014.12159.x, 2014.
12. Baird CRW, Fox P, Colvin LA: Gabapentinoid abuse in order to potentiate the effect of methadone: A survey among substance misusers. European Addiction Research 20:115–118, 2014.
13. Bozikas V, Petrikis P, Gamvrula K, et al.: Treatment of alcohol withdrawal with gabapentin. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26:197–199, 2002.
14. Pande AC, Crockatt JG, Janney.A, et al.: Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy. Bipolar Disorders 2:249–255, 2000.
15. Pande AC, Pollack MH, Crockatt J, et al.: Placebo-controlled study of gabapentin treatment of panic disorder. Journal of Clinical Psychopharmacology 20:467–471, 2000.
16. Pande AC, Davidson JRT, Jefferson, JW: Treatment of social phobia with gabapentin: A placebo-controlled study Journal of Clinical Psychopharmacology 19: 341–348, 1999.
17. Karam-Hage M, Brower KJ: Gabapentin treatment for insomnia associated with alcohol dependence. American Journal of Psychiatry. 157:151, 2000.
18. Rocha L, Ondarza-Rovira R, Maidment NT: Gabapentin modifies extracellular opioid peptide content in amygdala: A microdialysis study. Epilepsy Research 35:13–20, 1999.
19. Koob GF, Volkow ND: Neurocircuitry of addiction. Neuropsychopharmacology 35:217–238, 2010.